Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA.
Eur J Epidemiol. 2024 Jun;39(6):653-665. doi: 10.1007/s10654-024-01111-x. Epub 2024 May 4.
There is growing interest in incorporating metabolomics into public health practice. However, Black women are under-represented in many metabolomics studies. If metabolomic profiles differ between Black and White women, this under-representation may exacerbate existing Black-White health disparities. We therefore aimed to estimate metabolomic differences between Black and White women in the U.S. We leveraged data from two prospective cohorts: the Nurses' Health Study (NHS; n = 2077) and Women's Health Initiative (WHI; n = 2128). The WHI served as the replication cohort. Plasma metabolites (n = 334) were measured via liquid chromatography-tandem mass spectrometry. Observed metabolomic differences were estimated using linear regression and metabolite set enrichment analyses. Residual metabolomic differences in a hypothetical population in which the distributions of 14 risk factors were equalized across racial groups were estimated using inverse odds ratio weighting. In the NHS, Black-White differences were observed for most metabolites (75 metabolites with observed differences |0.50| standard deviations). Black women had lower average levels than White women for most metabolites (e.g., for N6, N6-dimethlylysine, mean Black-White difference = - 0.98 standard deviations; 95% CI: - 1.11, - 0.84). In metabolite set enrichment analyses, Black women had lower levels of triglycerides, phosphatidylcholines, lysophosphatidylethanolamines, phosphatidylethanolamines, and organoheterocyclic compounds, but higher levels of phosphatidylethanolamine plasmalogens, phosphatidylcholine plasmalogens, cholesteryl esters, and carnitines. In a hypothetical population in which distributions of 14 risk factors were equalized, Black-White metabolomic differences persisted. Most results replicated in the WHI (88% of 272 metabolites available for replication). Substantial differences in metabolomic profiles exist between Black and White women. Future studies should prioritize racial representation.
人们对将代谢组学纳入公共卫生实践越来越感兴趣。然而,在许多代谢组学研究中,黑人女性的代表性不足。如果黑人和白人女性的代谢组特征存在差异,这种代表性不足可能会加剧现有的黑人和白人健康差距。因此,我们旨在估计美国黑人和白人女性之间的代谢组差异。我们利用了来自两个前瞻性队列的的数据:护士健康研究(NHS;n=2077)和妇女健康倡议(WHI;n=2128)。WHI 作为复制队列。通过液相色谱-串联质谱法测量血浆代谢物(n=334)。使用线性回归和代谢物集富集分析估计观察到的代谢组差异。通过逆 Odds 比加权估计在假设的人群中,种族群体之间 14 个风险因素的分布相等时的剩余代谢组差异。在 NHS 中,黑人和白人之间观察到大多数代谢物的差异(75 种代谢物的观察差异|0.50|标准偏差)。与白人女性相比,黑人女性的大多数代谢物的平均水平较低(例如,对于 N6、N6-二甲基赖氨酸,平均黑人和白人差异=-0.98 个标准偏差;95%CI:-1.11,-0.84)。在代谢物集富集分析中,黑人女性的甘油三酯、磷脂酰胆碱、溶血磷脂酰乙醇胺、磷脂酰乙醇胺和有机杂环化合物水平较低,但磷脂酰乙醇胺血浆、磷脂酰胆碱血浆、胆固醇酯和肉碱水平较高。在假设的人群中,14 个风险因素的分布相等,黑人和白人的代谢组差异仍然存在。在 WHI 中,大多数结果得到了复制(272 种可复制代谢物中有 88%)。黑人和白人女性的代谢组特征存在很大差异。未来的研究应优先考虑种族代表性。